Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

BAI-3 Activators

BAI-3 Activators encompass a unique class of chemical compounds that serve to enhance the activity of Brain-specific Angiogenesis Inhibitor 3 (BAI-3), a protein encoded by the ADGRB3 gene. BAI-3 is part of the adhesion G protein-coupled receptor (GPCR) family, which plays a critical role in processes such as synapse formation, neural development, and angiogenesis. These activators function by binding to specific domains of BAI-3 or by influencing the cellular signaling pathways to which BAI-3 is integral. For instance, some activators may bind to the GPCR proteolytic site (GPS) of BAI-3, which is a critical region for its activation and subsequent signaling. By stabilizing the active conformation of BAI-3, these compounds can enhance its ability to mediate cell adhesion. Others might interact with the extracellular matrix and integrins, thereby facilitating the protein's role in neuron-neuron or neuron-glia interactions, which are essential for synaptic organization.

Additionally, certain BAI-3 Activators may indirectly promote BAI-3 activity by modulating intracellular signaling cascades that BAI-3 is known to influence. Some compounds may enhance the second messenger systems, such as cyclic AMP (cAMP), which further lead to the activation of protein kinase A (PKA) and other kinases that phosphorylate BAI-3, thus increasing its signaling efficacy. Other activators might work by altering the lipid composition of the neuronal membranes, which can affect the localization and function of BAI-3, leading to enhanced synaptic plasticity and neurogenesis. These chemical activators, through their precise and targeted actions, facilitate the biological functions of BAI-3 without altering its expression levels or requiring direct ligand binding. By doing so, they play a pivotal role in sustaining and regulating the physiological processes controlled by BAI-3, highlighting their significance in the fine-tuning of neural development and maintenance.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein, as a tyrosine kinase inhibitor, reduces competitive phosphorylation from other tyrosine kinase pathways, which could result in a relative increase in signaling processes that specifically activate BAI-3.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate (S1P) engages S1P receptors that can activate G-protein coupled pathways, potentially altering the cellular environment in a way that enhances BAI-3 activity.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin raises intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). Elevated calcium may activate calcium-dependent kinases and phosphatases that can indirectly upregulate BAI-3 activity.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a PKC activator that mimics diacylglycerol (DAG). Activation of PKC can lead to altered phosphorylation states of proteins involved in signaling pathways that could enhance BAI-3 activity.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is a kinase inhibitor that may preferentially inhibit kinases competing with those that directly activate BAI-3, thereby selectively enhancing BAI-3-related signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can diminish PI3K/Akt signaling, potentially allowing for the redirection of signaling resources towards pathways that upregulate BAI-3 activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that functions similarly to LY294002, potentially enhancing signaling pathways that activate BAI-3 by reducing PI3K/Akt pathway activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor that may shift signaling dynamics to favor pathways that activate BAI-3, as p38 MAPK inhibition can result in compensatory signaling through alternative pathways.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is an ionophore that increases intracellular calcium levels. Higher calcium can engage signaling proteins and pathways that amplify BAI-3 activity.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine, despite being a broad-spectrum kinase inhibitor, may preferentially inhibit kinases that negatively regulate pathways leading to BAI-3 activation, thereby indirectly enhancing BAI-3 signaling.